Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 28787259

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Oct 1
First author
Mossé YP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Mossé YP
      type
      Author
    2. name
      Voss SD
      type
      Author
    3. name
      Lim MS
      type
      Author
    4. name
      Rolland D
      type
      Author
    5. name
      Minard CG
      type
      Author
    6. name
      Fox E
      type
      Author
    7. name
      Adamson P
      type
      Author
    8. name
      Wilner K
      type
      Author
    9. name
      Blaney SM
      type
      Author
    10. name
      Weigel BJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Mossé YP
      type
      Author
    2. name
      Voss SD
      type
      Author
    3. name
      Lim MS
      type
      Author
    4. name
      Rolland D
      type
      Author
    5. name
      Minard CG
      type
      Author
    6. name
      Fox E
      type
      Author
    7. name
      Adamson P
      type
      Author
    8. name
      Wilner K
      type
      Author
    9. name
      Blaney SM
      type
      Author
    10. name
      Weigel BJ
      type
      Author
    bibliography ids
    1. nci-bib-0c1c8f409d33d2057194f9e0
    book metadata
    content sha256
    f7b817a275c6ccd212e26fd90026aaace004b54c3689f21f18a313a3be2da6a4
    document type
    citation
    dois
    1. 10.1200/JCO.2017.73.4830
    electronic publication date
    display
    2017 Aug 8
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:28787259
    immutable id
    pubmed:28787259@f7b817a275c6ccd212e26fd90026aaace004b54c3689f21f18a313a3be2da6a4
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    28
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3215-3221
    volume
    35
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      28787259
      provenance
      batch id
      fb25b16edcb1373b70c1
      provider
      NCBI PubMed ESummary
      record sha256
      4edfd471b100a8294fd6deaee683f988779550f3dc97ac3ae229beb06f9c45eb
      response sha256
      182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
      retrieved at
      2026-09-09T23:47:28.490065+00:00
      publication date
      display
      2017 Oct 1
      precision
      day
      year
      2017
      publication types
      1. Clinical Trial, Phase I
      2. Clinical Trial, Phase II
      3. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/28787259/
      title
      Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

      Preserved source evidence · Independent clinical review pending · Not medical advice